134 related articles for article (PubMed ID: 19251589)
1. NKT cell subsets mediate differential proatherogenic effects in ApoE-/- mice.
To K; Agrotis A; Besra G; Bobik A; Toh BH
Arterioscler Thromb Vasc Biol; 2009 May; 29(5):671-7. PubMed ID: 19251589
[TBL] [Abstract][Full Text] [Related]
2. CD4+ natural killer T cells potently augment aortic root atherosclerosis by perforin- and granzyme B-dependent cytotoxicity.
Li Y; To K; Kanellakis P; Hosseini H; Deswaerte V; Tipping P; Smyth MJ; Toh BH; Bobik A; Kyaw T
Circ Res; 2015 Jan; 116(2):245-54. PubMed ID: 25398236
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of Ly49 expression on CD4+ and CD4-CD8- (double negative) NK1.1+ T cells.
Sköld M; Cardell S
Eur J Immunol; 2000 Sep; 30(9):2488-96. PubMed ID: 11009081
[TBL] [Abstract][Full Text] [Related]
4. Regulation of NKT cells by Ly49: analysis of primary NKT cells and generation of NKT cell line.
Maeda M; Lohwasser S; Yamamura T; Takei F
J Immunol; 2001 Oct; 167(8):4180-6. PubMed ID: 11591738
[TBL] [Abstract][Full Text] [Related]
5. MHC-dependent and -independent modulation of endogenous Ly49 receptors on NK1.1+ T lymphocytes directed by T-cell receptor type.
Sköld M; Stenström M; Sidobre S; Höglund P; Kronenberg M; Cardell S
Immunology; 2003 Nov; 110(3):313-21. PubMed ID: 14632658
[TBL] [Abstract][Full Text] [Related]
6. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
7. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners.
Sun R; Tian Z; Kulkarni S; Gao B
J Immunol; 2004 May; 172(9):5648-55. PubMed ID: 15100309
[TBL] [Abstract][Full Text] [Related]
8. Natural killer T cells accelerate atherogenesis in mice.
Nakai Y; Iwabuchi K; Fujii S; Ishimori N; Dashtsoodol N; Watano K; Mishima T; Iwabuchi C; Tanaka S; Bezbradica JS; Nakayama T; Taniguchi M; Miyake S; Yamamura T; Kitabatake A; Joyce S; Van Kaer L; Onoé K
Blood; 2004 Oct; 104(7):2051-9. PubMed ID: 15113755
[TBL] [Abstract][Full Text] [Related]
9. Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets.
Johnston B; Kim CH; Soler D; Emoto M; Butcher EC
J Immunol; 2003 Sep; 171(6):2960-9. PubMed ID: 12960320
[TBL] [Abstract][Full Text] [Related]
10. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
[TBL] [Abstract][Full Text] [Related]
11. Quantitative and qualitative differences in proatherogenic NKT cells in apolipoprotein E-deficient mice.
Major AS; Wilson MT; McCaleb JL; Ru Su Y; Stanic AK; Joyce S; Van Kaer L; Fazio S; Linton MF
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2351-7. PubMed ID: 15472130
[TBL] [Abstract][Full Text] [Related]
12. Ly49C Impairs NK Cell Memory in Mouse Cytomegalovirus Infection.
Forbes CA; Scalzo AA; Degli-Esposti MA; Coudert JD
J Immunol; 2016 Jul; 197(1):128-40. PubMed ID: 27233959
[TBL] [Abstract][Full Text] [Related]
13. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
[TBL] [Abstract][Full Text] [Related]
14. A CD1d-dependent lipid antagonist to NKT cells ameliorates atherosclerosis in ApoE-/- mice by reducing lesion necrosis and inflammation.
Li Y; Kanellakis P; Hosseini H; Cao A; Deswaerte V; Tipping P; Toh BH; Bobik A; Kyaw T
Cardiovasc Res; 2016 Feb; 109(2):305-17. PubMed ID: 26604037
[TBL] [Abstract][Full Text] [Related]
15. Thymus-dependent modulation of Ly49 inhibitory receptor expression on NK1.1+gamma/delta T cells.
Hara T; Nishimura H; Hasegawa Y; Yoshikai Y
Immunology; 2001 Jan; 102(1):24-30. PubMed ID: 11168633
[TBL] [Abstract][Full Text] [Related]
16. MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells.
Fahlén L; Lendahl U; Sentman CL
J Immunol; 2001 Jun; 166(11):6585-92. PubMed ID: 11359811
[TBL] [Abstract][Full Text] [Related]
17. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
18. CD1d-independent NKT cells in beta 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells.
Maeda M; Shadeo A; MacFadyen AM; Takei F
J Immunol; 2004 May; 172(10):6115-22. PubMed ID: 15128797
[TBL] [Abstract][Full Text] [Related]
19. Natural killer T cells are required for lipopolysaccharide-mediated enhancement of atherosclerosis in apolipoprotein E-deficient mice.
Andoh Y; Ogura H; Satoh M; Shimano K; Okuno H; Fujii S; Ishimori N; Eshima K; Tamauchi H; Otani T; Nakai Y; Van Kaer L; Tsutsui H; Onoé K; Iwabuchi K
Immunobiology; 2013 Apr; 218(4):561-9. PubMed ID: 22954709
[TBL] [Abstract][Full Text] [Related]
20. Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functions.
Eger KA; Sundrud MS; Motsinger AA; Tseng M; Van Kaer L; Unutmaz D
PLoS One; 2006 Dec; 1(1):e50. PubMed ID: 17183680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
